<DOC>
	<DOCNO>NCT03081338</DOCNO>
	<brief_summary>Amyotrophic Lateral Sclerosis ( ALS ) else know Motor Neurone Disease ( MND ) rapidly progressive fatal neurological disease strike prime life , treatment . The principal aim management maintain quality life reduce symptom disease . This require multidisciplinary approach use best practice symptom alleviation , include innovation approach towards maximise quality life . The purpose study use exist information drawn partner country system care available people amyotrophic lateral sclerosis correct time , correct format cost effective manner . This achieve collect detail patient carer experience across stage diagnosis end life , include decision make terminal stage disease . A health economic analysis help identify overall cost disease management , provide model increase efficiency preserve maximize quality life , begin develop novel health economic measurement tool terminal neurological illness . The complete project provide user-friendly best practice programme amyotrophic lateral sclerosis modify management related degenerative disease nervous system .</brief_summary>
	<brief_title>A Programme Amyotrophic Lateral Sclerosis Care Europe</brief_title>
	<detailed_description>This prospective multi-centre observational research project carry 8 European partner 9 site : 1 Ireland ( Dublin ) , 1 Netherlands ( Utrecht ) , 2 United Kingdom ( UK ) ( Sheffield London ) , 2 Italy ( Turin Milan ) , 2 Germany ( Berlin Munich ) , 1 Belgium ( Leuven ) . In term data collection , study consist 3 substudies organise 6 interlinked work package span clinical , epidemiological health service research . All partner contribute participant recruitment collect comparable data , use fulfilling deliverable work package . Central co-ordination research activity 2 UK site undertaken Sheffield . This protocol concern research activity relation ALS-CarE project involve 2 UK-based participate site . Following ethical research governance approval , ALS-CarE officially start 1st April 2014 run 3 year . Participant recruitment commence follow ethical research governance approval occur first 4 month Sheffield King 's College MND Care Centres . The follow-up period participant take 12 month depend rate progression illness . Finally , period 11 month end project enable analysis data , dissemination finding report write . SCIENTIFIC SUMMARY Background : Amyotrophic Lateral Sclerosis ( ALS ) else know Motor Neurone Disease ( MND ) progressive neurodegenerative disease strike prime life . There currently effective disease modify therapy ALS death usually occur within 3 year symptom onset . Management palliative aim maximise quality life minimise burden disease . The complexity rapidly progressive nature ALS require responsive multidisciplinary care system build reliable disease stag evidence base symptom management . Aim : To incorporate detailed clinical information drawn population base source responsive care programme . Plan investigation : A standardise staging system validate , quality life patient experience measure management optimise across disease stage diagnosis end life . Health economic analysis identify key difference resource utilisation useful pharmaco-economic analysis new therapeutic . Potential impact : The complete project provide user-friendly best practice framework ALS modify management neurodegenerative disease .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>A diagnosis definite , probable , laboratory support possible ALS accord El Escorial criterion . Patient cognitive impairment extent complete inform consent process</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ALS , MND , Care , Patient journey</keyword>
</DOC>